Biotech Firm Immunis Rebrands, Unveils New Logo

Immunis, a clinical-stage biotech company, has revealed its new logo and brand identity.

The refresh is intended to showcase the American firm's "scientific focus on multi-pathway biology".

The new logo design is said to be inspired by a medicine the company has developed to tackle age-related and chronic diseases.

Known as "IMM01-STEM", it reportedly functions differently from standard therapies that target a single mechanism; it consists of 'regenerative factors' that work across many signalling pathways.

"The updated logo is inspired by the coordinated activity of secreted signalling factors and cellular pathways that drives functional improvements in muscle and metabolic health," says the Irvine, California-headquartered company.

Adding: "It represents a shift from a traditional single-target mindset to a systems-based approach that mirrors the complexity of human biology and ageing."

The broader brand identity introduces imagery centred on "movement, strength, and function," with a refined colour palette that is said to symbolise "a natural and warm energy that mirrors healthy ageing."

"Our new brand identity captures both the biological foundation of our platform and our commitment to developing therapies that help people live stronger, healthier lives," comments Dr. Hans Keirsted, chairman of Immunis.

"As our science advances, it is critical that our brand clearly communicates what makes Immunis different," states the firm's senior scientific communications manager, Dr. Karissa Munoz.

Source: Immunis